Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


04.06.2018

1 Biol Psychiatry
2 J Psychiatry Neurosci
1 Neuropsychopharmacology
1 Neurosci Lett
2 PLoS One
3 Psychiatry Res
12 Schizophr Res
1 Trends Neurosci


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biol Psychiatry

  1. SORENSEN HJ, Debost JC, Agerbo E, Benros ME, et al
    Polygenic Risk Scores, School Achievement, and Risk for Schizophrenia: A Danish Population-Based Study.
    Biol Psychiatry. 2018 May 3. pii: S0006-3223(18)31467.
    PubMed     Text format     Abstract available


    J Psychiatry Neurosci

  2. SCARR E, Hopper S, Vos V, Seo MS, et al
    Low levels of muscarinic M1 receptor-positive neurons in cortical layers III and V in Brodmann areas 9 and 17 from individuals with schizophrenia.
    J Psychiatry Neurosci. 2018;43:170202.
    PubMed     Text format     Abstract available

  3. SOLER J, Fananas L, Parellada M, Krebs MO, et al
    Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.
    J Psychiatry Neurosci. 2018;43:170066.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  4. HOLPER L, Ben-Shachar D, Mann JJ
    Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.
    Neuropsychopharmacology. 2018 May 16. pii: 10.1038/s41386-018-0090.
    PubMed     Text format     Abstract available


    Neurosci Lett

  5. DING N, Li Z, Liu Z
    Escitalopram augmentation improves negative symptoms of treatment resistant schizophrenia patients - A randomized controlled trial.
    Neurosci Lett. 2018 May 28. pii: S0304-3940(18)30371.
    PubMed     Text format     Abstract available


    PLoS One

  6. KAGEYAMA M, Solomon P
    Post-traumatic stress disorder in parents of patients with schizophrenia following familial violence.
    PLoS One. 2018;13:e0198164.
    PubMed     Text format     Abstract available

  7. TORDESILLAS-GUTIERREZ D, Ayesa-Arriola R, Delgado-Alvarado M, Robinson JL, et al
    The right occipital lobe and poor insight in first-episode psychosis.
    PLoS One. 2018;13:e0197715.
    PubMed     Text format     Abstract available


    Psychiatry Res

  8. BRETT BL, McGovern JE, Choi J, Fiszdon JM, et al
    Improving treatment motivation in individuals with psychosis: Predictors of response to motivational enhancement.
    Psychiatry Res. 2018;266:36-39.
    PubMed     Text format     Abstract available

  9. CHEN CK, Lee CY, Lee Y, Hung CF, et al
    Could schizoaffective disorder, schizophrenia and bipolar I disorder be distinguishable using cognitive profiles?
    Psychiatry Res. 2018;266:79-84.
    PubMed     Text format     Abstract available

  10. CAQUEO-URIZAR A, Fond G, Urzua A, Boyer L, et al
    Gender differences in schizophrenia: A multicentric study from three Latin-America countries.
    Psychiatry Res. 2018;266:65-71.
    PubMed     Text format     Abstract available


    Schizophr Res

  11. STUBBS B, Mueller C, Gaughran F, Lally J, et al
    Predictors of falls and fractures leading to hospitalization in people with schizophrenia spectrum disorder: A large representative cohort study.
    Schizophr Res. 2018 May 21. pii: S0920-9964(18)30267.
    PubMed     Text format     Abstract available

  12. BENSON TL, Park S
    Increased plasticity of bodily self-experience in individuals who may carry latent liability for schizophrenia.
    Schizophr Res. 2018 May 21. pii: S0920-9964(18)30261.
    PubMed     Text format     Abstract available

  13. LECEI A, Decoster J, De Hert M, Derom C, et al
    Evidence that the association of childhood trauma with psychosis and related psychopathology is not explained by gene-environment correlation: A monozygotic twin differences approach.
    Schizophr Res. 2018 May 21. pii: S0920-9964(18)30282.
    PubMed     Text format     Abstract available

  14. YANG TX, Cui XL, Wang Y, Huang J, et al
    Effect of emotional cues on prospective memory performance in patients with schizophrenia and major depressive disorder.
    Schizophr Res. 2018 May 24. pii: S0920-9964(18)30280.
    PubMed     Text format     Abstract available

  15. YANG Z, Lim K, Lam M, Keefe R, et al
    Factor structure of the positive and negative syndrome scale (PANSS) in people at ultra high risk (UHR) for psychosis.
    Schizophr Res. 2018 May 24. pii: S0920-9964(18)30281.
    PubMed     Text format     Abstract available

  16. YANG Y, Yang ZY, Zou YM, Shi HS, et al
    Low-pleasure beliefs in patients with schizophrenia and individuals with social anhedonia.
    Schizophr Res. 2018 May 24. pii: S0920-9964(18)30275.
    PubMed     Text format     Abstract available

  17. LEUCHT S, Chaimani A, Leucht C, Huhn M, et al
    60years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response.
    Schizophr Res. 2018 May 24. pii: S0920-9964(18)30266.
    PubMed     Text format     Abstract available

  18. RABALLO A, Monducci E, Ferrara M, Nastro PF, et al
    Developmental vulnerability to psychosis: Selective aggregation of basic self-disturbance in early onset schizophrenia.
    Schizophr Res. 2018 May 24. pii: S0920-9964(18)30269.
    PubMed     Text format     Abstract available

  19. XU DR, Gong W, Gloyd S, Caine ED, et al
    Measuring adherence to antipsychotic medications for schizophrenia: Concordance and validity among a community sample in rural China.
    Schizophr Res. 2018 May 25. pii: S0920-9964(18)30271.
    PubMed     Text format     Abstract available

  20. FOND G, Boyer L, Schurhoff F, Berna F, et al
    Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort.
    Schizophr Res. 2018 May 27. pii: S0920-9964(18)30265.
    PubMed     Text format     Abstract available

  21. TOLMACHEVA EA, Ognivov VV, Shevelenkova TD, Bastakov VA, et al
    The Muller-Lyer illusion in patients with schizophrenia and Parkinson's disease.
    Schizophr Res. 2018 May 28. pii: S0920-9964(18)30288.
    PubMed     Text format    

  22. MOTHI SS, Sudarshan M, Tandon N, Tamminga C, et al
    Machine learning improved classification of psychoses using clinical and biological stratification: Update from the bipolar-schizophrenia network for intermediate phenotypes (B-SNIP).
    Schizophr Res. 2018 May 25. pii: S0920-9964(18)30250.
    PubMed     Text format    


    Trends Neurosci

  23. JEZEQUEL J, Johansson EM, Leboyer M, Groc L, et al
    Pathogenicity of Antibodies against NMDA Receptor: Molecular Insights into Autoimmune Psychosis.
    Trends Neurosci. 2018 May 25. pii: S0166-2236(18)30115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: